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Aims and method Community treatment orders (CTOs) have been in used in
England and Wales since November 2008; however, their eﬀectiveness has been
debated widely, as has the question of which methodology is appropriate to
investigate them. This paper uses national data to explore the use of CTOs in
England.
Results About 5500 patients are subject to CTOs at any one time. Each year,
∼4500 patients are made subject to a CTO each year and ∼2500 are fully
discharged, usually by the responsible clinician; fewer than half of CTO patients are
recalled, and two-thirds of recalls end in revocation. The low rate of CTO discharges
by mental health tribunals (below 5%) suggests that they are not used
inappropriately.
Clinical implications The introduction of CTOs in England has coincided with a
reduction in psychiatric service provision due to the economic downturn. Pressures
on services might be even more severe if patients currently subject to CTOs instead
needed to be detained as in-patients.
Declaration of interest None.
Background
Community treatment orders (CTOs) were introduced into
legislation for England and Wales by the Mental Health
Act (MHA) 2007. They can be applied to a patient who is
already subject to a section of the MHA which makes them
liable to detention for treatment. The patient is discharged
from the treatment section on to a CTO, which broadly
means that they need to comply with a set of speciﬁed con-
ditions that may include accepting prescribed treatment.
The responsible clinician has the power to recall a patient
to hospital. If the CTO is revoked, the treatment section is
reinstated. CTOs are initially valid for 6 months but can
be extended indeﬁnitely. They are subject to scrutiny by
independent ﬁrst-tier mental tribunals (Mental Health), or
MHTs, which can discharge the patient from the CTO if
the grounds for its use, as laid out in the MHA, are deemed
not to be met. Following the introduction of CTOs, uptake
was initially higher than some had predicted, and over the
past few years usage seems to be fairly stable.1–3 The attitude
of many clinicians to CTOs has been favourable,4 but they
have also been the subject of controversy.4,5 The power to
coerce patients to accept treatment in the community clearly
represents a conﬂict between the principles of respecting
autonomy and of preventing harm to the patient and/or
others, and thus between providing the ‘least restrictive’
treatment option balanced against ‘preventive’ principles.6
The diﬃculties in resolving this conﬂict satisfactorily have
resulted in signiﬁcant variations in the nature and imple-
mentation of these orders in diﬀerent countries. Factors
which could reduce the usage of CTOs may include a reluc-
tance to use coercive measures, objections from patients’
advocates, concerns about liability, operational aspects and
the lack of a strong evidence base.7
CTOs are typically indicated for psychiatric patients,
usually with a diagnosis of psychosis, presenting with a
‘revolving door’ pattern of admissions secondary to poor
treatment adherence and poor engagement with psychiatric
services.8 Although a main aim of CTOs is to reduce read-
missions by preventing relapse, another motivation might
be to attempt to improve quality of life for patients and
their careers. The responsible clinician devises a set of con-
ditions appropriate to the individual patient in the CTO. The
responsible clinician has the discretion to recall the patient,
initially for a 72-h period, for further treatment if deemed
necessary. During this recall period, a clinical decision has
to be made as to whether the CTO should be revoked,
which leads to the patient returning to being subject to the
original hospital treatment section from which they were
discharged on to the CTO. Alternatively, they may receive
some brief intervention and be allowed to return to the com-
munity, or they may be informally admitted while continu-
ing to be subject to the CTO. The responsible clinician has
considerable discretion as to when to exercise the power of
recall. Some clinicians may aim to recall patients promptly,
with the aim of quickly re-establishing treatment and
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preventing further deterioration, possibly without needing
to revoke the CTO. Others may prefer to wait longer, in
the hope that things will improve without having to subject
the patient to a measure which may seem overly coercive or
even punitive. A recent follow-up study found that fewer
than half the patients subject to CTOs are recalled, with
about a ﬁfth being recalled multiple times.9 In that study,
half of these recalls were due to deterioration in clinical con-
dition and about 70% of recalls resulted in revocation.
Eﬀectiveness of CTOs
If CTOs were eﬀective and were used eﬀectively, they might
lead to an overall reduction in requirement for in-patient
treatment and a decline in the number of patients detained
on treatment sections.10 Two older American randomised
controlled studies (RCTs) of similar measures failed to
ﬁnd clinical beneﬁts, but it has been argued that they had
signiﬁcant methodological drawbacks, for example, in that
they excluded high-risk patients.11,12 Subsequent American
studies have claimed to demonstrate beneﬁts, especially
when considered as part of a wider public health system
involving the criminal justice system.7 Given the diﬀerence
in psychiatric service provision, these studies may have lim-
ited applicability to the UK. The OCTET study, a RCT which
was carried out soon after the introduction of CTOs, did not
ﬁnd clinical beneﬁts.13 However, this study has been criti-
cised as having signiﬁcant methodological problems, such
as again excluding high-risk patients and the fact that the
CTOs were only used for a brief period of time.14,15 Small
naturalistic UK clinical studies using before and after meth-
odologies have reported positive outcomes.16–18 Swartz and
Swanson (2015)15 suggested that RCTs may not be the best
way to study these complex tools, and that larger, naturalis-
tic studies may be more appropriate. A Care Quality
Commission (CQC) 2009/10 report claimed that a third of
CTO patients in England did not have a reported history
of non-adherence or disengagement.19
Figures from the Mental Health Minimum Data Set
show that the majority of people on CTOs are of working
age, and more than twice as many are male than female;
however, in the 65 and over age group, more women than
men are on CTOs.20 The descriptive data indicate that
patients are typically male and around 40 years of age,
with a long history of schizophrenia-like or serious aﬀective
illness, previous admissions, poor medication adherence,
aftercare needs, the potential for violence and displaying
psychotic symptoms, especially delusions, at the time of
the CTO.6 CTO usage is more prevalent in urban areas.21
Method
We examined national data on aspects of CTO usage along-
side that of other provisions of the MHA and information on
psychiatric service provision. National data from the annual
reports of Digital NHS (previously the Health and Social
Care Information Centre) and Mental Health Reports of
the CQC (the independent regulator of health and social
care in England since 2009/10) were studied to look at the
trends in implementation of CTOs. Thus, although CTOs
are used in both England and Wales, the results we report
are only for England.
Results
All the ﬁgures quoted in the results below and accompanying
tables were extracted from the NHS Digital report:
In-Patients Formally Detained in Hospitals Under the
Mental Health Act 1983, and Patients Subject to Supervised
Community Treatment: 2015/16, Annual Figures.21
As shown in Table 1, the annual rate of new CTOs is
fairly stable at around 4500, with the number of patients
subject to CTOs at any one time being around 5400. The
annual number of discharges from CTOs has steadily
increased over 5 years from 1712 (2011/12) to 2575 (2015/16),
and each year somewhat fewer than half of all patients subject
to a CTO are discharged.
As shown in Table 2, there are about 45 recalls per year
for every 100 patients subject to a CTO (HSCIC 2015/16).
Over the past 5 years, the average rate of revocation follow-
ing such recalls is 65%, albeit with a fair degree of variation
between years, with absolute numbers ﬂuctuating between
1000 and 1500. Table 3 shows that, including theseTable 1 Annual numbers of patients in England who are
subject to CTOs at any one time, along with the
number of new CTOs initiated and numbers and
percentages of patients discharged from CTOs




4764 5218 5365 5461 5426
Number of new
CTOs
4220 4647 4434 4564 4361
Number of CTO
discharges







35.9 41.4 41.6 45.6 47.5
Table 2 Annual number of recalls and numbers of recalls
per 100 patients subject to a CTO
Year 2011/12 2012/13 2013/14 2014/15 2015/16
Number of recalls
from CTO
2082 2272 2316 2369 2294
Recalls per 100
CTO patients
48 44 43 43 42
Number of
revocations




70.6 66.4 60.5 60.2 67.9
(Note that some patients may be recalled more than once.) Also shown are the
number of revocations and the percentage of recalls that result in revocation.
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revocations, around 9000 patients are detained under
Section 3 each year. Given that about 4500 patients are dis-
charged on a CTO annually, it seems that about half of
patients detained under Section 3 will be discharged on a
CTO.
Table 4 shows that each year patients make 3000–4000
applications to MHTs to be discharged from CTOs. Most
applications proceed to a hearing, and the proportion of
MHT hearings resulting in discharge was running at 4–5%,
falling to 3.3% in 2015/16 (CQC 2012/13, CQC 2013/14,
CQC 2014/15, CQC 2015/16). These rates are not dissimilar
to the rates for discharge from hospital treatment sections
(Section 3 and Section 37) of 4.4% in 2013/14, and less
than that for all sections, which was 8.9% (CQC 2013/14).
The application may not proceed to a hearing if it is with-
drawn by the patient or if the responsible clinician them-
selves discharges the CTO. Of all patients subject to a CTO
in a given year, the percentage discharged by a MHT is
around 2.5–3.5%. The low rates could partly be explained
by the higher proportions of automatic referrals made to
the tribunal by hospital managers, as opposed to applica-
tions made by patients.
The past few years have seen a 17% reduction in the
number of in-patient beds for people needing care for men-
tal health problems: from 26 448 in 2008/09 to 21 949 in
2012/13.22 HSCIC data (2015) show that annual patient
contact numbers have fallen signiﬁcantly, while patient
numbers are increasing.23 The same report also shows that
the greatest fall has been for assertive outreach services
(more than 20%) and general psychiatric, substance misuse
and forensic services (around 15% each). By contrast, contact
with criminal justice liaison and diversion services saw the
greatest increase in contacts (36.2%), while contact with psy-
chiatric liaison increased by almost 28%.
Discussion
The rate of CTO use is about 10 per 100 000 of the population,
which puts it in the low to moderate range by international
comparisonwith similar provisions for compulsory treatment
in the community. Australia and New Zealand and some parts
of the USA have much higher rates, whereas rates are much
lower in Canada and New York.24
The pattern of usage of CTOs seems to be fairly stable in
the context of ongoing reductions in psychiatric service pro-
vision. A CQC report claimed that the powers were being
applied ‘preventatively beyond those for whom they were
primarily designed’.19 However, we note that the rate of dis-
charge by MHTs is low and possibly falling, indicating that
these independent tribunals do not seem to regard CTOs
as being used inappropriately.
The number of recalls is nearly half the total number of
CTOs, and somewhat fewer than a third of CTOs are ended
by revocation. Again, the fact that such a large proportion of
patients subject to CTOs end up requiring readmission
might be taken as an indicator that CTOs are largely being
used appropriately, in an attempt to provide treatment in
the community to patients who would otherwise remain in
hospital. It is not possible to tell whether the number of
revocations could be reduced if patients were recalled
more promptly, at an earlier stage in their relapse, or
whether the revocations represent a group of patients who
are intrinsically diﬃcult to maintain in the community. It
would be helpful to investigate this aspect of clinical
practice.
It is diﬃcult to know the extent to which the use of
CTOs has allowed psychiatric services to continue to func-
tion with reduced bed provision. Of course, many would
argue that psychiatric services are in fact not functioning
at an acceptable level, and the rise in contacts with the crim-
inal justice system could be taken as evidence of this. The
MHT will uphold a CTO only if it feels that the CTO is
required for the patient to continue to accept treatment.
Clinically, adherence to treatment is aimed at preventing
relapse and hospital admission among ‘revolving door’
patients, and has wider signiﬁcance for psychiatric
in-patient service provision.
Overall, the success or failure of CTOs hinges on their
appropriate application and implementation. There may
well be large diﬀerences in practice between services and
individuals; it would be helpful to explore these systematic-
ally and, if possible, relate them to outcome measures. Large
numbers of patients are subjected to this provision, so it
would seem sensible to take whatever steps possible to see
that it is used eﬀectively.
Table 3 Annual number of patients newly detained under
Section 3 (S3) of the MHA, number of CTO revo-
cations and the sum of these two numbers
Year 2011/12 2012/13 2013/14 2014/15
Non-CTO Section 3 7701 7776 7481 7690
Revocations from CTO 1469 1509 1401 1427
Total 9170 9285 8882 9117
Table 4 Annual numbers of applications to MHTs for dis-
charge from CTO, numbers of hearings, and num-
bers and percentages of hearings resulting in














4764 5218 5365 5461 5426
Applications to
MHT
3901 4211 4431 4349 4317
MHT hearings 3272 3169 3550 3629 3942
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